HTML
-
Species identification was carried out by performing sequence alignment using BLASTn (GenBank, USA) (Figures 1, 2). The filamentous fungal isolate was identified to be A. niger, showing a sequence identity of 98%. A phylogenetic tree was generated using the minimum evolution method (Figure 3) and the data were re-sampled 1, 000 times. The strain No. 9 was found to be in the same branch as A. niger, showing the closest evolutionary distance and a homology of 99.87%. Based on colony characteristics and the internally transcribed spacer (ITS) sequence analysis of the strain, the isolate was determined to be A. niger.
-
The ORAC assay has been extensively used to measure the antioxidant activity of many cereal and fruit extracts based on their peroxyl radical scavenging activities[25]. The antioxidant activities of FA-WB were evaluated in vitro using the ORAC assay. As shown in Table 1, a higher ORAC value (34.22 ± 1.76 mmol TE/g) was detected in FA-WB, which was considerably higher than that of ordinary ferulic acid (23.77 ± 2.03 mmol TE/g). It means that FA-WB showed higher in vitro antioxidant activity than ordinary ferulic acid. In addition, the CAA value of FA-WB was 79.6 ± 0.026 μmol QE/100 μmol ferulic acid, which was higher than that of the ferulic acid standard (59.8 ± 0.031 μmol of QE/100 μmol). This indicated that FA-WB exhibited stronger cellular antioxidant activity compared to ordinary ferulic acid.
Composition EC50 (μmol) ORAC (mmol TEa/g) CAA (μmol QEb/100 μmol ferulic acid) Quercetin 4.63 ± 0.27 FA-WB 6.74 ± 0.01 34.22 ± 1.76 79.61 ± 0.02 Ferulic acid standerd 7.91 ± 0.01 23.77 ± 2.03 59.82 ± 0.03 Note. aTE, tocopherol equivalent; bQE, quercetin equivalents. Table 1. ORAC Values, CAA Values, and EC50 of Cellular Antioxidant Activities of Two Different Ferulic Acid
-
The antioxidant ability of FA-WB was further examined using erythrocyte hemolysis and plasma oxidation assays. In the erythrocyte hemolysis assay, AAPH, which can decompose at 37 ℃ to generate an alkyl radical, was used as an initiator. In the presence of oxygen, these alkyl radicals are converted to peroxyl radicals that can cause lipid peroxidation and loss of erythrocyte membrane integrity, ultimately leading to hemolysis. Hemolysis of erythrocytes has been used extensively as an ex vivo model for studying the protective effect of antioxidants[26-28]. Compared with other phenolic acids, such as chlorogenic acid, ρ-coumaric acid, caffeic acid, sinapic acid, trans-ferulic acid, and syringic acid, ferulic acid exhibited the highest antioxidant activity[10, 29]. We thus examined the antioxidant activity of FA-WB. The purity of the ferulic acid was determined to be 93.8%.
We used a well-established AAPH-induced red blood cell (RBC) damage model to evaluate the antioxidant activity of FA-WB by measuring erythrocyte hemolysis, MDA content, ROS level, and the enzymatic activity of SOD, CAT, and GPx.[30] As expected, direct addition of 200 mmol/L AAPH to the RBCs dramatically caused erythrocyte hemolysis (Figure 4A), triggered RBC membrane permeabilization (Figure 4B), induced ROS production (Figure 4F), and increased intracellular enzymatic activity of CAT, GPx, and SOD (Figure 4C-E) after 2.5 h of treatment. Pre-incubation of RBCs with at least 25 μmol/L FA-WB significantly reduced these adverse effects. Moreover, the increase in FA-WB content reversed the AAPH-induced RBC damage in a concentration-dependent manner (Figure 4A-F).
Figure 4. Protective Effects of FA-WB on AAPH-induced Erythrocyte Hemolysis Assay (A); Changes in MDA Content (B) and Enzyme Activities of CAT (C), GPx (D), and SOD (E) in Erythrocytes; Inhibitory Activity of Ferulic Acid on AAPH-induced ROS Overexpression in Sheep Erythrocytes (F). Different lower case letters indicate significant differences (P < 0.05) in multiple-range analysis among the groups.
As shown in Figure 4A, erythrocyte hemolysis induced by AAPH was effectively attenuated by FA-WB in a dose-dependent manner, such that the inhibition rate was enhanced as the FA-WB concentration increased from 0 to 100 μg/mL. At a dose of 100 μg/mL, the hemolysis rate of FA-WB was 15.0%, which was comparable to that of vitamin C (6.7% at 1 mg/mL). AAPH-induced ROS generation can cause lipid peroxidation and result in the release of MDA. MDA is involved in tumor promotion, cellular metabolism disruption, and cell membrane dysfunction; excess MDA can ultimately lead to disruption of cellular metabolism. As seen in Figure 4B, the MDA level in erythrocytes was significantly increased from 1.5 to 15.5 nmol/L after treatment with 200 mmol/L AAPH for 2 h, indicating the occurrence of lipid peroxidation caused by AAPH-induced oxidative stress. For cells incubated with different concentrations of FA-WB, the level of MDA in erythrocytes was decreased, especially with the high concentration of FA-WB (100 μg/mL), wherein the MDA concentration declined to 5.4 nmol/L. For cells incubated with FA-WB without AAPH supplementation, the MDA level was comparable to that of the control, indicating that FA-WB itself does not induce MDA formation. Thus, lipid peroxidation caused by ROS generation was efficiently inhibited by FA-WB. The major radical scavenging antioxidant enzymes in the human body include SOD, GPx, and CAT. These enzymes constitute an intracellular defense system, which can coordinate the elimination of free radicals through a series of chain reactions. The activities of SOD, GPx, and CAT in erythrocytes were significantly increased after 200 mmol/L AAPH treatment for 2 h, showing that AAPH treatment activated the enzymatic antioxidant defense systems in erythrocytes. This was particularly the case for high concentration (100 μg/mL) FA-WB treatment, which maintained the enzyme activities at normal levels. Thus, FA-WB can effectively attenuate AAPH-induced oxidative stress in erythrocytes, mainly through the inhibition of ROS generation, as illustrated in Figure 5.
Figure 5. Possible intracellular antioxidant detoxifying mechanisms of FA-WB that attenuate aaph-induced oxidative stress through inhibition of ROS generation[22].
To further evaluate the protective effect of FA-WB on erythrocyte morphology after AAPH oxidation, we used scanning electron microscopy to image the RBCs pre-treated with FA-WB. As shown in Figure 6A, AAPH incubation alone caused irregular membrane blebbing and even membrane rupture in erythrocytes (Figure 6B). RBCs pre-treated with 50 μmol/L FA-WB displayed less stressed morphology (Figure 6C); with 100 μmol/L FA-WB pre-treatment, RBCs displayed almost normal morphology, similar to the group without AAPH treatment (Figure 6D). Ferulic acid possesses three distinctive structural motifs that can contribute to its free radical scavenging capability[31, 32]. Our data indicated that FA-WB possesses potent free radical-scavenging ability and can protect RBCs from oxidative damage.
Figure 6. Scanning electron micrographs of erythrocytes after FA-WB and AAPH treatment. Human RBCs were Pre-treated with 0 μmol/L (AAPH only, B), 50 μmol/L (C) and 100 μmol/L (D) Ferulic acid prior to incubation with 120 mmol/L AAPH. The normal human RBCs were used as no treatment control (A). Scale bar, 10 μm.
-
Pre-treatment of macrophages with ferulic acid reduced LPS-induced inflammation[33, 34]. We tested whether FA-WB can inhibit secretion of inflammatory cytokines TNF-α and IL-6 using supernatant collected from LPS-stimulated RAW264.7 cells. LPS alone induced significant amounts of TNF-α and IL-6 production. Addition of FA-WB gradually reduced TNF-α and IL-6 secretion in a concentration-dependent manner. There was no significant difference between FA-WB at a lower concentration and the control group. However, FA-WB at 125 μg/mL significantly suppressed TNF-α and IL-6 secretion by 23% and 26%, respectively, relative to LPS alone. FA-WB at 500 μg/mL inhibited TNF-α and IL-6 secretion by 51.4% and 83.9%, respectively (Figure 7A-B). This inhibitory effect was not caused by cell death as FA-WB does not show significant cytotoxicity to macrophages (Figure 7C).